The approval allows treatment of heart failure patients irrespective of the ejection fraction based on new trial DELIVER conducted by AstraZeneca
The Long-term Safety Trial was approved to be conducted by China National Medical Products Administration (NMPA) on 18 April 2023
CMOs showed an increasing reluctance to take on debt in 2022
This transformation will enable GE HealthCare to build a strong foundation for business growth
Planned investment of approximately USD 90 million to build a state-of-the-art Sandoz Biosimilar Technical Development Center in Ljubljana, Slovenia by 2026
The two-part production system is proven to yield high-quality proteins from GS-CHO cell lines, a prevalent mammalian host cell for protein production
Evonik specializes in mid- to large-scale, later clinical phase HPAPIs
This product will be launched through Granules Consumer Health (GCH) division
Advances clinical research capabilities with leading regulatory grade registries platform
The company has received Export Performance Award - API & Intermediaries Gold Star for the year 2021-22
Subscribe To Our Newsletter & Stay Updated
